PrintFriendly

Print Friendly, PDF & Email

New Medscape Activity Reviews Current and Emerging Treatments for Hemophilia A

January 2, 2018
New activity for Providers

“Current and Emerging Treatment Options for Hemophilia A: A Clinician’s Review,” is the latest educational opportunity available from Medscape. It is intended for hematologists, pediatricians, and other healthcare professionals who treat patients with hemophilia. The goal of the activity is to review the current treatment options for hemophilia A, challenges to optimal treatment, and future research directions.

Upon completion, participants will:

  • Have increased knowledge regarding the:
    • Available factor VIII therapies
    • Potential role of emerging agents in the hemophilia treatment paradigm
  • Demonstrate greater confidence in their ability to:
    • Individualize prophylaxis based on patient characteristics, lifestyle, and pharmacokinetics

Current and Emerging Treatment Options for Hemophilia A: A Clinician's Review
Jonathan C. Roberts, MD
CME / ABIM MOC Released: 12/8/2017; Valid for credit through: 12/8/2018

If you are already registered with Medscape follow this link to access this activity. If you are not registered, simply go to Medscape.org where registration is straightforward and free of charge.